Background:
Coronaviruses (CoVs), having enveloped RNA of positive strand, are mainly responsible for
enzootic infections in mammals. The mortality of CoVs has been proved as they can cross the species barrier very easily
and infect humans. Most recently, the outbreak of coronavirus induced COVID-19 emerged in the city of Wuhan, Hubei
province of China and became the third highly pathogenic coronavirus infecting nearly 230 countries.
Objective:
To review the literature available about pathogenic Coronavirures with emphasis on pathogenesis of COVID19, and passive antibody therapy prospective.
Method:
This study reviewed relevant published literature to provide (1) structural similarities between coronaviruses and
therapeutic methodologies used on SARS-CoV, MERS treatment which might help scientists in understanding novel
COVID-19 infection, (2) understanding COVID-19 pathogenesis that may help in identification of appropriate therapeutic
targets to develop specific and effective anti-viral drug as well as immunizing agents against this novel emerging
pathogen and (3) to discuss existing knowledge on the passive immune therapy against similar coronaviruses SARS-CoV
and MERS-CoV with emphasis on COVID-19 pandemic treatment.
Conclusion:
COVID 19 coronavirus have shown resemblance to viral infections like SARS-CoV, MERS infection.
Historically, it has been proved that prevention of disease when exposed to biological system is mainly a function of
immune response of that infected individual. To fight against these infections, passive anibody therapy is the only
available counter measure which could provide immediate immunity against infection. Passive antibody results in
protection irrespective of the immune status of the host. This therapy can be advantageous in countering biological attack,
post exposure preventions, low toxicity and peculiar activity.